Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Neuron23

News headline image
Neuron23 to Accelerate Expansion of NEULARK Phase 2 Trial with Support from The Michael J. Fox Foundation
From Neuron23
Via Business Wire
News headline image
Neuron23 Announces Publication in PNAS Highlighting the Important Role of TYK2 in Neuroimmunology
From Neuron23
Via Business Wire
News headline image
Neuron23 to Present Phase 1 Healthy Volunteer Data of NEU-411, a Brain-penetrant LRRK2 Inhibitor, at AD/PD™ 2025
From Neuron23
Via Business Wire
News headline image
Neuron23 Announces First-in-human Dose in Phase 1 Clinical Trial of NEU-111, a TYK2 Inhibitor with Best-in-class Potential for Immune-mediated Inflammatory Disorders
From Neuron23
Via Business Wire
News headline image
Neuron23 Unveils Groundbreaking Phase 2 Trial in Early Parkinson’s Disease
From Neuron23
Via Business Wire
News headline image
Neuron23 Announces Usage of Roche’s Digital Biomarker and Device in Parkinson’s Disease Clinical Trial
From Neuron23
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.